Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02684968 · ClinicalTrials.gov registry record · NA

Effects of Continuous Bilateral QL Analgesia After Open Abdominal Surgery

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02684968 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02684968, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Eligible patients will be randomized 1:1 without stratification to bilateral continuous QL catheters with local anesthetic continuous infusion (QL block + IV patient-controlled analgesia group) or normal saline continuous infusion (IV patient-controlled analgesia group). In the postanesthesia care unit (PACU), patients will be given intravenous boluses of hydromorphone or fentanyl as needed. Following immediate recovery from anesthesia, patients will be provided with a hydromorphone IV patient-controlled analgesia pump with standard initial settings and an option of clinician dose for breakthrough pain. IV patient-controlled hydromorphone pump settings will be titrated to comfort level (pain score\<4) by blinded clinicians. Each of the catheters will be connected to patient controlled infusion pump running at a basal rate of 6mL/hour of 0.1% Bupivacaine or normal saline with on-demand bolus of 5 mL every 60 minutes to be started in the operating room before the surgical incision. Opioid consumption first 72 hours or until discharge, whichever comes first will be recorded. Pain scores during first 72 hours or until discharge, whichever comes first will be recorded with a verbal rating scale and obtained from the patient's electronic medical records. The morning of post operative day 1 and post operative day 3 the ORSDS and QOR surveys will be completed. Morning of the day of discharge, the overall patient satisfaction with pain management survey will be completed.

Interventions

  • PROCEDURE Colorectal surgery

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-03
Est. Completion 2019-10
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT02684968

The ClinicalTrials.gov registry entry for NCT02684968 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Colorectal surgery is the first listed.

NCT02684968 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02684968 about?

NCT02684968 is a clinical study titled "Effects of Continuous Bilateral QL Analgesia After Open Abdominal Surgery". Eligible patients will be randomized 1:1 without stratification to bilateral continuous QL catheters with local anesthetic continuous infusion (QL block + IV patient-controlled analgesia group) or normal saline continuous infusion (IV patient-controlled analgesia group). In the postanesthesia care ...

What is the current status of trial NCT02684968?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-03. Estimated completion is 2019-10.

What interventions are being tested in trial NCT02684968?

The interventions under investigation include: Colorectal surgery (PROCEDURE).

Who is sponsoring clinical trial NCT02684968?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.